Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 272

    1.

    Pharmaceutical price controls and patient welfare.

    Calfee JE.

    Ann Intern Med. 2001 Jun 5;134(11):1060-4.PMID: 11388819 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes.

    Ioannides-Demos LL, Ibrahim JE, McNeil JJ.

    Pharmacoeconomics. 2002;20(9):577-91. Review.PMID: 12141886 [PubMed - indexed for MEDLINE]Related articles

    4.

    Role of the pharmaceutical industry in health care cost containment.

    Craine RB Jr.

    Am J Cardiol. 1985 Aug 23;56(5):43C-46C.PMID: 3927698 [PubMed - indexed for MEDLINE]Related articles

    5.

    Market power in the United States red meatpacking industry.

    Koontz SR.

    Vet Clin North Am Food Anim Pract. 2003 Jul;19(2):519-44. Review.PMID: 12951745 [PubMed - indexed for MEDLINE]Related articles

    6.

    European healthcare policies for controlling drug expenditure.

    Ess SM, Schneeweiss S, Szucs TD.

    Pharmacoeconomics. 2003;21(2):89-103.PMID: 12515571 [PubMed - indexed for MEDLINE]Related articles

    7.

    The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services.

    Stebbins MR, Kaufman DJ, Lipton HL.

    J Manag Care Pharm. 2005 May;11(4):333-41.PMID: 15871644 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The economics of parallel trade.

    Danzon PM.

    Pharmacoeconomics. 1998 Mar;13(3):293-304. Review.PMID: 10178655 [PubMed - indexed for MEDLINE]Related articles

    9.

    The increasing necessity for market-based pharmaceutical prices.

    Calfee JE.

    Pharmacoeconomics. 2000;18 Suppl 1:47-57. Review.PMID: 11151309 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.

    Davidova J, Praznovcova L, Lundborg CS.

    Pharm World Sci. 2008 Jan;30(1):57-64. Epub 2007 Jun 23.PMID: 17588212 [PubMed - indexed for MEDLINE]Related articles

    11.

    The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.

    Openshaw MS.

    Nurs Econ. 2005 Nov-Dec;23(6):307-11, 279. Review.PMID: 16459902 [PubMed - indexed for MEDLINE]Related articles

    12.

    Price regulation in the pharmaceutical industry: prescription or placebo?

    Abbott TA 3rd.

    J Health Econ. 1995 Dec;14(5):551-65.PMID: 10156501 [PubMed - indexed for MEDLINE]Related articles

    13.

    Do pharmaceutical prices respond to potential patient out-of-pocket expenses?

    Pavenik N.

    Rand J Econ. 2002 Autumn;33(3):469-87.PMID: 12585303 [PubMed - indexed for MEDLINE]Related articles

    14.

    The high cost of medicines in Ireland. Is it time to change the pricing mechanism?

    Tilson L, McGowan B, Bennett K, Barry M.

    Eur J Health Econ. 2004 Dec;5(4):341-4.PMID: 15452737 [PubMed - indexed for MEDLINE]Related articles

    15.

    The pricing of pharmaceuticals: an international comparison.

    Dickson M.

    Clin Ther. 1992 Jul-Aug;14(4):604-10; discussion 603.PMID: 1525794 [PubMed - indexed for MEDLINE]Related articles

    16.

    Future European health care: cost containment, health care reform and scientific progress in drug research.

    Emilien G.

    Int J Health Plann Manage. 1997 Apr-Jun;12(2):81-101.PMID: 10173136 [PubMed - indexed for MEDLINE]Related articles

    17.

    The effect of generic competition on the price of brand-name drugs.

    Lexchin J.

    Health Policy. 2004 Apr;68(1):47-54.PMID: 15033552 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.

    Aaserud M, Dahlgren AT, Kösters JP, Oxman AD, Ramsay C, Sturm H.

    Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005979. Review.PMID: 16625648 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects]

    Stargardt T, Schreyögg J, Busse R.

    Gesundheitswesen. 2005 Jul;67(7):468-77. German. PMID: 16103970 [PubMed - indexed for MEDLINE]Related articles

    20.

    Price controls and global pharmaceutical progress.

    Scherer FM.

    Health Aff (Millwood). 2009 Jan-Feb;28(1):w161-4. Epub 2008 Dec 16.PMID: 19088103 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data